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ABSTRACT
Background: Feline eosinophilic keratoconjunctivitis is a proliferative eye lesion of chronic aspect with usually unilateral 
presentation that may initiate as a superficial vascularization that evolves to a proliferative, granular, irregular lesion of 
whitish-pink aspect. With its association with an immune-mediated response, nonsteroidal anti-inflammatories do not 
appear to be efficient, although few studies describe its use. This case report describes a case of a feline eosinophilic kera-
toconjunctivitis with its clinical evolution since the use of nonsteroidal topical anti-inflammatory drug in an undiagnosed 
patient and the transition to a topical corticosteroid and cure after 14 days since diagnosis.
Case: An 8-year-old female cat was attended at the Veterinary Hospital of the Dom Bosco Catholic University (UCDB), 
with main complaint being an eye injury with at least 36 days of evolution and unresponsive to treatment (topical tobra-
mycin 0.3% every 12 h / ketorolac trometamol 0.5%/ every 12 h and ophthalmic lubricant/every 4 h). Since the patient 
had free access to the street, the owners suspected of trauma-induced lesion. At physical examination, it was observed a 
proliferative lesion at the peri-limbal superotemporal quadrant of the right cornea with approximately 0.4 cm diameter, 
with color varying of pale to pink, with irregular surface and low vascularity, the adjacent conjunctiva was also affected 
with similar multiple nodular lesions (0.1 cm). Fluorescein test was negative as well as FIV/FeLV immunochromatography 
testing. Feline herpesvirus investigation was not possible. The patient was anesthetized and a lesion specimen was acquired 
with a cotton swab scraping and a fine needle aspiration. Cytology showed predominance of eosinophils and mast cells, 
with rare corneal epithelial cells, with smear background containing mast cell granules and free eosinophils. Presumptive 
diagnosis was eosinophilic keratoconjunctivits. After 14 days of topical corticosteroid (prednisolone acetate 1% every 8 h) 
the patient showed complete remission of the lesions with no relapse in 48 days.
Discussion: Misdiagnosis and consequently mistreatment seems a greater prejudice than the risks associated with sample 
collection of keratoconjunctival proliferative lesions. Due to the lack of cytobrush or cotton swab, apparently, the reported 
patient was not submitted to ophthalmic cytology due to reluctance of the staff regarding fine needle aspiration of the cornea 
lesion. Despite a greater risk of iatrogenic trauma with needle aspiration, with eye anatomy well defined, bevel size and 
movement amplitude respected, it is unlikely that severe complications could occur. In this case, the undiagnosed patient 
was submitted to unnecessary 15 days of topical antibiotic and nonsteroidal anti-inflammatory, and no improvement of 
the clinical signs was observed. Despite non-recommended, few clinical trials as well as case descriptions are available 
comparing nonsteroidal and corticosteroid treatment of the disease. Once with diagnosis and beginning of topical predniso-
lone acetate 1% exclusively, the patient showed continuous improvement until complete remission of clinical signs after 
14 days. This report reinforces the recommendation of corticosteroid therapy for feline eosinophilic keratoconjunctivitis 
and the absence of efficacy of nonsteroidal drugs. It also highlights the importance of diagnosis before any medical treat-
ment is considered.
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INTRODUCTION
Feline eosinophilic keratitis or eosinophilic 
keratoconjunctivits (FEK) is a proliferative cornea-
-conjunctiva lesion, possibly associated with an 
immune-mediated response that may be related with 
feline herpesvirus infection [4].
Usually, cytology evaluation is sufficient for 
diagnosis, with eosinophils and mast cells as predo-
minant cells, but sample collection can be challenging 
considering the different aspects and sizes that ophthal-
mic lesions may present [8,12].
Treatment involves use of topical corticosteroid 
or other immunomodulatory drugs, and it is usually 
curative, while nonsteroidal topical anti-inflammato-
ries (NSAIs) show lack of efficiency [1].
Considering the aspect of potential diagnostic 
challenge as well as scarce information with the use of 
NSAIs for FEK treatment, a case report is described 
focusing on cytology sampling and the comparison be-
tween treatment with NSAI and corticosteroid therapy.
CASE
An 8-year-old domestic short-haired female 
sterile cat, with the main complaint being an eye injury 
with at least 36 days of evolution, was attended at the 
Veterinary Hospital of the Dom Bosco Catholic Uni-
versity (UCDB) - MS. The patient was being treated 
exclusively with topical drugs [tobramycin1 0.3% - one 
drop every 12 h; ketorolac trometamol1 0.5% - one drop 
every 12 h; and ophthalmic lubricant2 - every 4 h] and 
no improvement was observed within 15 days.
It seems that as no cytobrush or cotton swab 
were available, no sample collection was made con-
sidering staff reluctance with fine needle aspiration 
(FNA) and its possible complications. The owners 
also considered traumatic-associated injury, since the 
patient had free access to the street.
At physical examination, it was observed a 
proliferative lesion at the peri-limbal superotemporal 
quadrant of the right cornea with approximately 0.4 
cm diameter, with color varying from pale (borders) 
to pink (center), with irregular surface and low vascu-
larity. The adjacent conjunctiva was also affected with 
similar multiple nodular lesions (0.1 cm) [Figure 1A].
Fluorescein3 test was negative as well as FIV/
FeLV immunochromatography4 testing. Feline herpes-
virus investigation was not possible.
The patient was anesthetized with intravenous 
propofol5 [induction with 6 mg/kg/bolus and mainte-
nance with 0.2 mg/kg/min]. For analgesia, a single 
dose of methadone5 was administered (0.2 mg/kg/IM). 
One drop of anesthetic topical solution6 (tetracaine 
chlorhydrate 1%, phenylephrine chlorhydrate 1%) 
was instilled three min previously to sample collec-
tion. Lesion specimen was acquired with a previously 
dampened (drop of 0.9% sterile solution) cotton swab 
scraping7 (Figure 1B) and a FNA (25Gx1/2”)8 [Figure 
1C]. The FNA was performed without attachment to 
a syringe, only with gentle vertical movements in the 
main lesion. Both procedures were easily performed, 
with no immediate or post complications observed.
Cytology showed predominance of eosinophils 
and mast cells, rare corneal epithelial cells, with smear 
background containing mast cell granules and free eo-
sinophils. Presumptive diagnosis was of eosinophilic 
keratoconjunctivits [7].
After 14 days of topical corticosteroid [predni-
solone acetate9 1% - one drop every 8 h] exclusively, 
the patient showed complete remission of the lesions 
(Figure1D) with no relapse in 48 days.
DISCUSSION
The term “eosinophilic keratitis” seems better 
replaced by “eosinophilic keratoconjunctivitis” since, 
usually, the conjunctiva is also affected in this disease 
[4]. That was observed in the patient of this report, 
which along with a main cornea lesion, also presented 
smaller nodular lesions of the same color and aspect 
at the adjacent scleral conjunctiva.
Even when the lesion is of classic description, 
no aspect of FEK is pathognomonic [1,4,8,10]. That 
considered, routine and easily available complemen-
tary tests such as fluorescein dye and cytology should 
be performed whenever possible.
Cytobrush, commonly used for endocervical 
sampling in women, found itself as a usable tool in 
different situations of cytology sampling. Its use on 
superficial ophthalmic lesions seems already conso-
lidated, with good quality of material acquirement 
concomitant to minimal injury to the eye [6,7,12]. 
The bristles found on cytobrush probably have more 
potential to efficiently scrape the lesion than a cotton 
swab, for example.
Oppositely, fine needle aspiration of cornea 
and conjunctiva lesions are more prone to compli-
cations, since its natural puncture characteristic. The 
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risk of an iatrogenic corneal perforation is higher if 
compared to a smooth-brush-material object such as 
the cytobrush [6]. It is understanding that if the pro-
fessional does not feel secure, such procedure should 
not be performed and referral should be considered.
Nonetheless, to the author’s experience, if 
the professional recognizes all anatomic structures 
and takes into account depth of lesion, bevel size and 
amplitude of movement, any serious iatrogenic lesions 
would hardly occur. Additionally, for such delicate le-
sions, it seems that attachment to a syringe and negative 
pressure would hardly be necessary, as well as would 
increase the risk of iatrogenic perforations.
A 25Gx1/2” needle without attachment to a 
syringe and gentle vertical movements were sufficient 
for a good sample, allowing diagnosis in this case. 
Even though no quality graduation was performed, the 
pathologist noted that the use of fine needle aspiration 
for preparing slide smears was slightly superior in 
relationship to cell count evaluation in comparison to 
the use of cotton swab.
Recommended FEK treatment involves the use 
of topical corticosteroids and/or immunomodulatory 
drugs [4,10]. It seems that the mechanism of action of 
corticosteroids in this disease may be associated with 
controlling the immune response more than its anti-
-inflammatory effect with inhibition of the synthesis 
of arachidonic acid, since NSAIs shows absolutely 
no improvement of the associated lesions in FEK, 
and drugs such as cyclosporine leads to complete 
remission and cure [1,10]. Topical megestrol acetate 
0.5%, a progestin, also appears to be effective in this 
disease, but despite its glucocorticoid-associated effect, 
it is not completely elucidated if immunomodulation 
could also occur [3,11].
Figure 1. A- An 8-year-old female cat with an eosinophilic keratoconjunctivitis lesion. B- Sampling with a dampened cotton swab scraping. C- Sampling 
with a 25Gx1/2” needle. D- Complete remission of the lesion after 14-day treatment with topical prednisolone acetate 1%.
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However, the complete mechanism of action 
remains purely speculation, since no clinical trials were 
found that considered corticosteroid dose-effect, for 
example. Topical ophthalmic treatment does not follow 
the classical dosage based in weight, and that is clearly 
observed in veterinary patients since cats and horses, 
both with eosinophilic associated keratitis, virtually 
receive the same dose of local medication with similar 
clinical outcomes [4,5]. That postulated, it appears that 
it is unknown if increase of NSAI topical concentration 
could have more efficient cyclooxygenase inhibition 
that would lead to any kind of response in FEK.
Scarce information regarding topical NSAI 
was found, and despite a case report describing its 
failure in treating FEK, the name of the principle and 
concentration were not cited [1]. As for the case des-
cribed in this report, the use of ketorolac trometamol 
0.5% did not result in any response, and the lesion 
seemed to be stationary.
If species extrapolation is considered, vernal 
keratoconjunctivits in humans could be similar to FEK, 
since eosinophils are the most predominant lesion cell. 
In that disease, ketorolac trometamol 0.5% as well as 
diclofenac sodium 0.1% have shown to be effective in 
controlling clinical symptoms (i.e. itching, photopho-
bia) [2,9]. Still, even then, topical corticosteroid is the 
treatment of choice.
In this case, since diagnosis, complete inter-
ruption of the previous treatment and institution of 
monotherapy with topical corticosteroid (prednisolone 
acetate 1%) resulted in progressive improvement of the 
lesion, with complete remission within 14 days. Since 
topical tobramycin 0.3% was also used in the first 
prescription, it should also be considered the absence 
of primary bacteria etiology in FEK, since cure was 
achieved even with discontinuation of the antibiotic. 
Also, with no indication of bacteria involvement such 
as cases with purulent discharge, rational use of anti-
microbials is advised.
It is expected that this report aid other pro-
fessionals with impossibility of ophthalmic referral, 
with guidance such as cytology of proliferative kera-
toconjunctiva disorders, reinforcing the importance 
of diagnosis for an effective and focused treatment. 
It also evidences the inefficiency of topical ketorolac 
trometamol 0.5% (NSAI) and tobramycin 0.3% (anti-
biotic) in a FEK case.
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